Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis

There is a need for new combination regimens for tuberculosis. Identifying synergistic drug combinations can avoid toxic side effects and reduce treatment times. Using a fluorescent rifampicin conjugate, we demonstrated that synergy between cell wall inhibitors and rifampicin was associated with inc...

Descripción completa

Detalles Bibliográficos
Autores principales: McNeil, Matthew B., Chettiar, Somsundaram, Awasthi, Divya, Parish, Tanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470358/
https://www.ncbi.nlm.nih.gov/pubmed/32974492
http://dx.doi.org/10.1099/acmi.0.000006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470358/
https://www.ncbi.nlm.nih.gov/pubmed/32974492
http://dx.doi.org/10.1099/acmi.0.000006

Ejemplares similares